Navigation Links
Portola Pharmaceuticals Announces Positive Phase II EXPERT Results,and Additional Oral and Poster Presentations at the XXI Congress of,the International Society on Thrombosis and Haemostasis (ISTH)

ar disease. Portola is currently developing two clinical stage antithrombotics. Portola's lead compound, PRT054021, is an oral Factor Xa inhibitor for the prevention of venous thromboembolism after orthopedic surgery, for stroke prevention in patients with atrial fibrillation and for secondary prevention of myocardial infarction (MI) and stroke. Portola's second compound, PRT060128, is an oral and intravenous ADP receptor antagonist for patients with acute coronary syndrome, for the prevention of cardiovascular events in patients undergoing percutaneous coronary intervention and for secondary prevention of MI and stroke.

CONTACT: Dan Budwick of BMC Communications, +1-212-477-9007, Ext. 14, forPortola Pharmaceuticals, Inc.

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery
3. Portola Pharmaceuticals Presents Positive Phase I Data of Its ADP Receptor Antagonist at the American College of Cardiology
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:8/27/2015)...  Mytrus, a technology and services company revolutionizing clinical trials, announced ... has received approval for use by Britain,s ... first time e-Consent technology will be used in a ... Mytrus was also the first electronic informed consent ... the U.S. Food and Drug Administration in 2011. It ...
(Date:8/27/2015)... CAESAREA, Israel , August 27, 2015 ... Equity today announced a private investment in public equity ... up to $28.4 million in Itamar Medical.   ... the largest shareholder of Itamar Medical and will work ... market expansion. According to the investment agreement, ...
(Date:8/27/2015)... 27, 2015 The Elekta Linac-based ... Boston on July 9th for its ... to more fully exploit the potential of advances in ... diseases. "As an established provider of sophisticated ... assume a leadership role - in collaboration with its ...
Breaking Medicine Technology:Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 2Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 3Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 4Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 5Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 6Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 7Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 2Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 3Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 4Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 5New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 3
... 2011 Noverca – the first and currently only Italian ... its presence in the Health and Wellness Sector . ... treatment has been developed and launched thanks to the long-term ... N o verca) and Fatebenefratelli Hospital. ...
... SPRING, Md., April 8, 2011 The U.S. Food ... respirator, a device that kills 99.99 percent of three ... surface. (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... as a single-use, N95 surgical respirator for use in ...
Cached Medicine Technology:EXTENDED HEALTH: Noverca Enters the World of Healthcare 2FDA Clears Single-Use Antibacterial Surgical Respirator 2
(Date:8/28/2015)... RESTON, Va. (PRWEB) , ... August 28, 2015 ... ... Innovation , which is dedicated to distributing health information technology innovation to transform ... industry survey. Results of the survey will be de-identified and aggregated before being ...
(Date:8/28/2015)... ... August 28, 2015 , ... Popular ... 5 millionaire dating sites . According to the listings, MillionaireMatch.com ... in this category. , A spokesperson of Top5MillionaireDatingSites.com said, “This website ...
(Date:8/28/2015)... ... August 28, 2015 , ... A complimentary webinar offered by ... & Medicaid Services’ (CMS) proposal to mandate bundled payments through the Comprehensive ... Ready for Game Day: Comprehensive Care for Joint Replacement,” takes place at 12 noon ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... dating, companionship, and marriage? , MillionaireMatchmakerOnline.net is set up to help quality singles ... active members on the site are rich, gorgeous, well educated, or attractive. , ...
(Date:8/27/2015)... ... August 28, 2015 , ... Shortening the school week to ... mathematics, according to researchers at Georgia State University and Montana State University. , ... the impact of a four-day school week on student achievement by comparing fourth-grade ...
Breaking Medicine News(10 mins):Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2Health News:Top5MillionaireDatingSites.com Publishes Its First List of Reviews of the Best Millionaire Dating Sites 2Health News:PYA Offers Complimentary CCJR Webina — Game On 2Health News:PYA Offers Complimentary CCJR Webina — Game On 3Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 2Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 3Health News:Four-Day School Week Can Improve Academic Performance, Study Finds 2Health News:Four-Day School Week Can Improve Academic Performance, Study Finds 3
... Alberta biochemist has recreated the three-dimensional structure of ... if mutated, causes, hereditary breast cancer.Using ultra-sensitive x-ray ... the three dimensional structure of an important part ... in BRCA1 cause about half of all hereditary ...
... Grant Magnuson Clinical Center shows that by using radiofrequency ... them. The non-surgical technique, used increasingly for kidney and ... in the human body. // ,During radiofrequency ... tumor and radiofrequency energy applied through the needle tip ...
... How about siblings? If so, you might have a better memory ... lies in a part of the brain called the corpus callosum, ... a family history of left-handedness, says study author Steven Christman. // ... fibers that connects the two sides of our brain and is ...
... Drug Administration (FDA) approved a gel that promises ... The FDA had initially rejected Lifecore Biomedical Inc.'s ... certain gynecologic operations. // ,The gel, ... intended to reduce adhesions, internal scar tissue that ...
... stem cell lines could accrue genetic abnormalities over time and ... Burt Vogels, chairman of a key stem cell research committee ... said that every time a cell divide in a tissue ... certain problems too. ,Stem cells are unspecialized cells that ...
... permanently in the eye is safe and effective for treating ... laser operations that correct nearsightedness by reshaping the cornea, the ... of the University of Wisconsin School of Medicine in Madison ... of a multicenter trial of patients who had received the ...
Cached Medicine News:Health News:A need for new stem cell lines 2
... screening of factor-V-related APC resistance. The high ... the factor V:Q506 mutation is obtained by ... of V-DEF Plasma bioreagent. The test design ... and homozygous factor V genotypes. It also ...
Inquire...
Inquire...
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
Medicine Products: